PUBLISHER: Acute Market Reports | PRODUCT CODE: 1255984
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1255984
Vaccine Contract Manufacturing Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
An extensive portfolio of vaccines and constant rising demand has rendered the vaccine contract manufacturing market to be highly competitive with vast presence of key players across geographies. Along with safety and effectiveness of vaccines, flooding the market with one's product clutches equal importance. In order to cater to the rising demand for vaccines and maintaining uniform quality, leading industrial players tend to outsource manufacturing of vaccines to third parties to expedite market entry.
Rising awareness of immunization across geographies contributes to the overall market growth of vaccine contract manufacturing. Additionally, government initiatives enforcing immunization globally has led to rising vaccine demand. The Global Vaccine Action Plan (GVAP) by the World Health Organization (WHO) is an initiative to prevent deaths via expanding the access of vaccines by 2020. As of May 2017, Health ministries across 194 countries endorsed a new initiative on strengthening immunization to meet the goals of GVAP. As per the WHO, around 19.5 million infants worldwide were still not provided with necessary vaccines. The ever-rising need for vaccines, and with established players primarily focusing on the development of other molecules, outsourcing is mostly the preferred choice. Additionally, in developing nations, the lack of suitable manufacturing set up and skilled labour compels them to engage with contract manufacturers in order to cater to market standards.
Vaccine contract manufacturers comply with the Good Manufacturing Practices and provide concerned quality assurance review documents. With newer advancements in vaccine production, the contract vendors constantly upgrade their production facilities providing up-to-date services. With initial development process taking place by industrial leaders, third parties are approached for scaling up processes.
Continuous partnerships and acquisitions further catalyse the overall market growth. In October 2017, DCPrime BV a firm developing dendritic cell vaccines for cancer therapy collaborated with apceth Biopharma GmbH contract manufacturer. The collaboration comprises clinical batch production and the development of an expanded scale manufacturing process for cancer vaccines. However, a few large pharmaceutical firms prefer to maintain vaccine manufacturing in-house to avoid risks of management contingencies and deviation in safety and efficacy. This factor could have a negative impact on the global adoption of contract-based services during the forecast period.
Rising demand for expedited entry of vaccines into the market has rendered the vaccine contract manufacturing market to be highly competitive with a vast outreach across geographies. The key industrial players enjoying a dominant position in this market are Ajinomoto Althea, Inc., Albany Molecular Research, Inc., Cobra Biologics & Pharmaceutical Services, Cytovance Biologics; Catalent, Inc., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., ICON plc., IDT Biologika GmbH, Lonza Group, Ltd., Merck KGaA, Paragon Bioservices, Inc., PRA Health Sciences and Others notable players.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Vaccine Contract Manufacturing market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Vaccine Contract Manufacturing market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Service
Cell line/strain development
Upstream process development
Downstream process development
Analytical development
Stability testing
Product release
Application
Human use
Veterinary
Region Segment (2021-2031; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report:
What are the key micro and macro environmental factors that are impacting the growth of Vaccine Contract Manufacturing market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2031.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Vaccine Contract Manufacturing market?
Which is the largest regional market for Vaccine Contract Manufacturing market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Vaccine Contract Manufacturing market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Vaccine Contract Manufacturing market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Vaccine Contract Manufacturing Market
- 2.2. Global Vaccine Contract Manufacturing Market, By Service, 2022 (US$ Million)
- 2.3. Global Vaccine Contract Manufacturing Market, By Application, 2022 (US$ Million)
- 2.4. Global Vaccine Contract Manufacturing Market, By Geography, 2022 (US$ Million)
- 2.5. Attractive Investment Proposition by Geography, 2022
3. Vaccine Contract Manufacturing Market: Competitive Analysis
- 3.1. Market Positioning of Key Vaccine Contract Manufacturing Market Vendors
- 3.2. Strategies Adopted by Vaccine Contract Manufacturing Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2022 Versus 2031
4. Vaccine Contract Manufacturing Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Vaccine Contract Manufacturing Market Value, 2021 - 2031, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2022 Versus 2031
- 5.3. Market Segmentation
- 5.3.1. Cell line/strain development
- 5.3.2. Upstream process development
- 5.3.3. Downstream process development
- 5.3.4. Analytical development
- 5.3.5. Stability testing
- 5.3.6. Product release
6. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2022 Versus 2031
- 6.3. Market Segmentation
- 6.3.1. Human use
- 6.3.2. Veterinary
7. North America Vaccine Contract Manufacturing Market, 2021-2031, USD (Million)
- 7.1. Market Overview
- 7.2. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 7.3. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 7.4.Vaccine Contract Manufacturing Market: By Region, 2021-2031, USD (Million)
- 7.4.1.North America
- 7.4.1.1. U.S.
- 7.4.1.1.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 7.4.1.1.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 7.4.1.2. Canada
- 7.4.1.2.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 7.4.1.2.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 7.4.1.3. Rest of North America
- 7.4.1.3.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 7.4.1.3.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 7.4.1.1. U.S.
- 7.4.1.North America
8. UK and European Union Vaccine Contract Manufacturing Market, 2021-2031, USD (Million)
- 8.1. Market Overview
- 8.2. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 8.3. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 8.4.Vaccine Contract Manufacturing Market: By Region, 2021-2031, USD (Million)
- 8.4.1.UK and European Union
- 8.4.1.1. UK
- 8.4.1.1.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 8.4.1.1.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 8.4.1.2. Germany
- 8.4.1.2.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 8.4.1.2.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 8.4.1.3. Spain
- 8.4.1.3.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 8.4.1.3.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 8.4.1.4. Italy
- 8.4.1.4.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 8.4.1.4.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 8.4.1.5. France
- 8.4.1.5.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 8.4.1.5.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 8.4.1.6. Rest of Europe
- 8.4.1.6.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 8.4.1.6.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 8.4.1.1. UK
- 8.4.1.UK and European Union
9. Asia Pacific Vaccine Contract Manufacturing Market, 2021-2031, USD (Million)
- 9.1. Market Overview
- 9.2. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 9.3. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 9.4.Vaccine Contract Manufacturing Market: By Region, 2021-2031, USD (Million)
- 9.4.1.Asia Pacific
- 9.4.1.1. China
- 9.4.1.1.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 9.4.1.1.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 9.4.1.2. Japan
- 9.4.1.2.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 9.4.1.2.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 9.4.1.3. India
- 9.4.1.3.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 9.4.1.3.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 9.4.1.4. Australia
- 9.4.1.4.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 9.4.1.4.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 9.4.1.5. South Korea
- 9.4.1.5.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 9.4.1.5.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 9.4.1.6. Rest of Asia Pacific
- 9.4.1.6.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 9.4.1.6.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 9.4.1.1. China
- 9.4.1.Asia Pacific
10. Latin America Vaccine Contract Manufacturing Market, 2021-2031, USD (Million)
- 10.1. Market Overview
- 10.2. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 10.3. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 10.4.Vaccine Contract Manufacturing Market: By Region, 2021-2031, USD (Million)
- 10.4.1.Latin America
- 10.4.1.1. Brazil
- 10.4.1.1.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 10.4.1.1.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 10.4.1.2. Mexico
- 10.4.1.2.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 10.4.1.2.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 10.4.1.3. Rest of Latin America
- 10.4.1.3.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 10.4.1.3.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 10.4.1.1. Brazil
- 10.4.1.Latin America
11. Middle East and Africa Vaccine Contract Manufacturing Market, 2021-2031, USD (Million)
- 11.1. Market Overview
- 11.2. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 11.3. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 11.4.Vaccine Contract Manufacturing Market: By Region, 2021-2031, USD (Million)
- 11.4.1.Middle East and Africa
- 11.4.1.1. GCC
- 11.4.1.1.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 11.4.1.1.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 11.4.1.2. Africa
- 11.4.1.2.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 11.4.1.2.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 11.4.1.3. Rest of Middle East and Africa
- 11.4.1.3.1. Vaccine Contract Manufacturing Market: By Service, 2021-2031, USD (Million)
- 11.4.1.3.1. Vaccine Contract Manufacturing Market: By Application, 2021-2031, USD (Million)
- 11.4.1.1. GCC
- 11.4.1.Middle East and Africa
12. Company Profile
- 12.1. Ajinomoto Althea, Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Portfolio
- 12.1.4. Strategic Initiatives
- 12.2. Albany Molecular Research, Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Portfolio
- 12.2.4. Strategic Initiatives
- 12.3. Cobra Biologics & Pharmaceutical Services
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Portfolio
- 12.3.4. Strategic Initiatives
- 12.4. Cytovance Biologics
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Portfolio
- 12.4.4. Strategic Initiatives
- 12.5. Catalent, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Portfolio
- 12.5.4. Strategic Initiatives
- 12.6. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Portfolio
- 12.6.4. Strategic Initiatives
- 12.7. ICON plc.
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Portfolio
- 12.7.4. Strategic Initiatives
- 12.8. IDT Biologika GmbH
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Portfolio
- 12.8.4. Strategic Initiatives
- 12.9. Lonza Group, Ltd.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Portfolio
- 12.9.4. Strategic Initiatives
- 12.10. Merck KGaA
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Portfolio
- 12.10.4. Strategic Initiatives
- 12.11. Paragon Bioservices, Inc.
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Portfolio
- 12.11.4. Strategic Initiatives
- 12.12. PRA Health Sciences
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Portfolio
- 12.12.4. Strategic Initiatives
- 12.13. Others notable players
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Portfolio
- 12.13.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 2 Global Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 3 North America Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 4 North America Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 5 U.S. Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 6 U.S. Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 7 Canada Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 8 Canada Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 9 Rest of North America Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 10 Rest of North America Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 11 UK and European Union Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 12 UK and European Union Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 13 UK Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 14 UK Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 15 Germany Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 16 Germany Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 17 Spain Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 18 Spain Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 19 Italy Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 20 Italy Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 21 France Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 22 France Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 23 Rest of Europe Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 24 Rest of Europe Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 25 Asia Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 26 Asia Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 27 China Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 28 China Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 29 Japan Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 30 Japan Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 31 India Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 32 India Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 33 Australia Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 34 Australia Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 35 South Korea Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 36 South Korea Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 37 Latin America Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 38 Latin America Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 39 Brazil Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 40 Brazil Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 41 Mexico Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 42 Mexico Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 43 Rest of Latin America Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 44 Rest of Latin America Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 45 Middle East and Africa Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 46 Middle East and Africa Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 47 GCC Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 48 GCC Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 49 Africa Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 50 Africa Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
- TABLE 51 Rest of Middle East and Africa Vaccine Contract Manufacturing Market By Service, 2021-2031, USD (Million)
- TABLE 52 Rest of Middle East and Africa Vaccine Contract Manufacturing Market By Application, 2021-2031, USD (Million)
List of Figures
- FIG. 1 Global Vaccine Contract Manufacturing Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Vaccine Contract Manufacturing Market: Quality Assurance
- FIG. 5 Global Vaccine Contract Manufacturing Market, By Service, 2022
- FIG. 6 Global Vaccine Contract Manufacturing Market, By Application, 2022
- FIG. 7 Global Vaccine Contract Manufacturing Market, By Geography, 2022
- FIG. 8 Market Geographical Opportunity Matrix - Global Vaccine Contract Manufacturing Market, 2022
- FIG. 9 Market Positioning of Key Vaccine Contract Manufacturing Market Players, 2022
- FIG. 10 Global Vaccine Contract Manufacturing Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
- FIG. 11 Global Vaccine Contract Manufacturing Market, By Service, 2022 Vs 2031, %
- FIG. 12 Global Vaccine Contract Manufacturing Market, By Application, 2022 Vs 2031, %
- FIG. 13 U.S. Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 14 Canada Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 15 Rest of North America Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 16 UK Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 17 Germany Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 18 Spain Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 19 Italy Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 20 France Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 21 Rest of Europe Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 22 China Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 23 Japan Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 24 India Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 25 Australia Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 26 South Korea Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 27 Rest of Asia Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 28 Brazil Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 29 Mexico Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 30 Rest of Latin America Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 31 GCC Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 32 Africa Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
- FIG. 33 Rest of Middle East and Africa Vaccine Contract Manufacturing Market (US$ Million), 2021 - 2031
